Lv11
70 积分 2024-09-01 加入
Investigational agents targeting alarmins for asthma treatment: insights and progress from phase I and II trials
1个月前
已完结
How to build anti-PD1 agonist antibodies
1个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
1个月前
已完结
Autoimmune TCRs cross-react with microbial and self-antigens
1个月前
已完结
Precision immunotherapy: TRBV9+ T-cell depletion in ankylosing spondylitis
1个月前
已完结
Autoimmune TCRs cross-react with microbial and self-antigens
1个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
2个月前
已完结
Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphoma
2个月前
已完结
Novel immunotherapeutics against LGR5 to target multiple cancer types
4个月前
已完结
Novel immunotherapeutics against LGR5 to target multiple cancer types
4个月前
已关闭
皖公网安备34019202002308
